Cited by 20Gastrointestinal motility and disordersGastroesophageal reflux and treatmentsHelicobacter pylori-related gastroenterology studies

Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia

Open access
Sakaguchi, Masahiro·2012·World Journal of Gastroenterology

Abstract

AIM: To compare efficacy of proton pump inhibitors (PPIs) with H(2)-receptor antagonists (H(2)RAs) plus prokinetics (Proks) for dysmotility-like symptoms in functional dyspepsia (FD). METHODS: Subjects were randomized to receive open-label treatment with either rabeprazole 10 mg od (n = 57) or famotidine 10 mg bid plus mosapride 5 mg tid (n = 57) for 4 wk. The primary efficacy endpoint was change (%) from baseline in total dysmotility-like dyspepsia symptom score. The secondary efficacy endpoint was patient satisfaction with treatment. RESULTS: The improvement in dysmotility-like dyspepsia symptom score on day 28 was significantly greater in the rabeprazole group (22.5% ± 29.2% of baseline) than the famotidine + mosapride group (53.2% ± 58.6% of baseline, P < 0.0001). The superior benefit of rabeprazole treatment after 28 d was consistent regardless of Helicobacter pylori status. Significantly more subjects in the rabeprazole group were satisfied or very satisfied with treatment on day 28 than in the famotidine + mosapride group (87.7% vs 59.6%, P = 0.0012). Rabeprazole therapy was the only significant predictor of treatment response (P < 0.0001), defined as a total symptom score improvement ≥ 50%. CONCLUSION: PPI monotherapy improves dysmotility-like symptoms significantly better than H(2)RAs plus Proks, and should be the treatment of first choice for Japanese FD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3748/wjg.v18.i13.1517

Cites

35 of 35 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

  • Cites a retracted work: 10.1002/14651858.cd001960.pub3

    Major

    The cited work was retracted on 2011-02-16 (notice 10.1002/14651858.cd001960.pub4), before this paper was published (2012). Its authors could have known.

    Cited work 10.1002/14651858.cd001960.pub3 · retracted 2011-02-16 · notice 10.1002/14651858.cd001960.pub4 · this paper published 2012

  • Cites a retracted work: 10.1002/14651858.cd001960

    Major

    The cited work was retracted on 2011-02-16 (notice 10.1002/14651858.cd001960.pub4), before this paper was published (2012). Its authors could have known.

    Cited work 10.1002/14651858.cd001960 · retracted 2011-02-16 · notice 10.1002/14651858.cd001960.pub4 · this paper published 2012

2 of 2

Cites

2 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sakaguchi, M.
Corresponding author
Sakaguchi, Masahiro
Venue
World Journal of Gastroenterology
Published
2012
Volume
18
Issue
13
Pages
1517
ISSN
1007-9327 (ISSN-L)
OpenAlex
W2135149483
Cited by
20
References
35
Citations by year
2025: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2017: 4 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 5
FWCI
2.21
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • World Journal of Gastroenterology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • World Journal of Gastroenterology
Topics
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Gastroenterology › Gastroesophageal reflux and treatments
  • Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
Keywords
functional dyspepsia, proton pump inhibitors, rabeprazole, H2 receptor antagonists, famotidine, prokinetic agents, mosapride, Helicobacter pylori, treatment satisfaction, predictors of treatment response, Japanese patients
MeSH terms
Adult, Aged, Anti-Ulcer Agents, Benzamides, Dyspepsia, Female, Gastrointestinal Agents, Histamine H2 Antagonists, Humans, Male, Middle Aged, Morpholines, Esophageal Motility Disorders, Famotidine, Helicobacter pylori, Helicobacter Infections, Patient Satisfaction, 2-Pyridinylmethylsulfinylbenzimidazoles, Proton Pump Inhibitors, Rabeprazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review